Goldman initiated coverage on Enhabit Inc. with a new price target
$EHAB
Medical/Nursing Services
Health Care
Goldman initiated coverage of Enhabit Inc. with a rating of Neutral and set a new price target of $15.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/9/2024 | $8.25 → $9.50 | Hold → Buy | Jefferies |
| 5/14/2024 | $8.50 | Underperform → Market Perform | Leerink Partners |
| 5/9/2024 | $14.00 → $8.75 | Buy → Hold | Jefferies |
| 3/7/2024 | $9.50 | Sell → Neutral | UBS |
| 12/12/2023 | $12.00 | Market Perform | TD Cowen |
| 6/20/2023 | $10.00 | Underperform | SVB Securities |
| 3/16/2023 | $15.00 | Neutral | Goldman |
| 12/13/2022 | $18.00 | Market Perform | CJS Securities |
Jefferies upgraded Enhabit Inc. from Hold to Buy and set a new price target of $9.50 from $8.25 previously
Leerink Partners upgraded Enhabit Inc. from Underperform to Market Perform and set a new price target of $8.50
Jefferies downgraded Enhabit Inc. from Buy to Hold and set a new price target of $8.75 from $14.00 previously
8-K - Enhabit, Inc. (0001803737) (Filer)
10-Q - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference. Enhabit's President and CEO Barb Jacobsmeyer and Chief Financial Officer Ryan Solomon will participate in a fireside chat on Tuesday, June 10, at 10 a.m. EDT. The fireside chat will be webcast live and available for replay at https://investors.ehab.com. About Enhabit Home Health & Hospice Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what's possible for patient care in the home. Enhabit's team of clinicians supports patients and their familie
Company to host a conference call tomorrow, May 8, 2025, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2025. "Enhabit's first quarter 2025 results are a product of steadfast execution of our strategies," said Barb Jacobsmeyer, president and CEO of Enhabit. "Home health census grew 3.7% sequentially and hospice census grew 12.3% year over year. The combination of strong growth, improved profitability and continued balance sheet improvements resulted in a leverage ratio now below 4.5 times. This enables us to formally exit the covenant relief period restrictions in our
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May 7, 2025, and host a webcast and conference call on May 8, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 8, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast link: https://events.q4inc.com/attendee/885393432 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice Enhabit Home Hea